- Home
- RVNC vs GHG Comparison
RVNC vs GHG Comparison
Compare RVNC & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- GHG
- Stock Information
- Founded
- RVNC 1999
- GHG 2004
- Country
- RVNC United States
- GHG China
- Employees
- RVNC N/A
- GHG N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- GHG Hotels/Resorts
- Sector
- RVNC Health Care
- GHG Consumer Discretionary
- Exchange
- RVNC Nasdaq
- GHG Nasdaq
- Market Cap
- RVNC 320.5M
- GHG 259.8M
- IPO Year
- RVNC 2014
- GHG 2018
- Fundamental
- Price
- RVNC $3.09
- GHG $2.46
- Analyst Decision
- RVNC Hold
- GHG
- Analyst Count
- RVNC 9
- GHG 0
- Target Price
- RVNC $8.45
- GHG N/A
- AVG Volume (30 Days)
- RVNC 3.6M
- GHG 13.3K
- Earning Date
- RVNC 11-07-2024
- GHG 11-21-2024
- Dividend Yield
- RVNC N/A
- GHG 4.12%
- EPS Growth
- RVNC N/A
- GHG N/A
- EPS
- RVNC N/A
- GHG 0.28
- Revenue
- RVNC $256,945,000.00
- GHG $201,166,731.00
- Revenue This Year
- RVNC $11.28
- GHG N/A
- Revenue Next Year
- RVNC $27.21
- GHG $8.78
- P/E Ratio
- RVNC N/A
- GHG $8.74
- Revenue Growth
- RVNC 25.82
- GHG N/A
- 52 Week Low
- RVNC $2.30
- GHG $2.31
- 52 Week High
- RVNC $9.75
- GHG $4.10
- Technical
- Relative Strength Index (RSI)
- RVNC 33.47
- GHG 37.95
- Support Level
- RVNC $3.06
- GHG $2.42
- Resistance Level
- RVNC $3.09
- GHG $2.71
- Average True Range (ATR)
- RVNC 0.11
- GHG 0.09
- MACD
- RVNC 0.02
- GHG -0.01
- Stochastic Oscillator
- RVNC 6.90
- GHG 12.89
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.